Literature DB >> 8440273

Active removal of radioactivity in the blood circulation using biotin-bearing liposomes and avidin for rapid tumour imaging.

I Ogihara-Umeda1, T Sasaki, H Nishigori.   

Abstract

In order to shorten the delay between the administration of tumour-imaging agents and obtainment of scintigrams, rapid delivery of radionuclide to tumours followed by rapid clearance from the blood is required. We used liposomes with biotin bound on their surface (B-liposomes) as carriers for rapid delivery. For rapid blood clearance, we employed avidin in the expectation that the strong affinity between biotin and avidin would result in the aggregation of B-liposomes in the blood circulation, and that these aggregates would be taken up rapidly by the reticuloendothelial system, resulting in the rapid elimination of liposomes and the radionuclide encapsulated in them. When B-liposomes encapsulating gallium-67 deferoxamine were intravenously administered to mice bearing sarcoma 180, large amounts of 67Ga were delivered to tumours by 4 h after injection, though the 67Ga blood level remained high. On the other hand, administration of avidin 4 h after administration of the B-liposomes dramatically reduced the blood level so that it was only 5% of that in the non-treated group 1 h later. As a result, the tumour-to-blood ratio reached nearly 14 at 5 h after radionuclide administration, suggesting that rapid tumour-imaging will be feasible by means of this method.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440273     DOI: 10.1007/bf00168879

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  AVIDIN. 1. THE USE OF (14-C)BIOTIN FOR KINETIC STUDIES AND FOR ASSAY.

Authors:  N M GREEN
Journal:  Biochem J       Date:  1963-12       Impact factor: 3.857

2.  Increased delivery of gallium-67 to tumors using serum-stable liposomes.

Authors:  I Ogihara-Umeda; S Kojima
Journal:  J Nucl Med       Date:  1988-04       Impact factor: 10.057

3.  Investigations of avidin and biotin for imaging applications.

Authors:  D J Hnatowich; F Virzi; M Rusckowski
Journal:  J Nucl Med       Date:  1987-08       Impact factor: 10.057

4.  Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors.

Authors:  I Ogihara-Umeda; S Kojima
Journal:  Eur J Nucl Med       Date:  1989

5.  Development of a liposome-encapsulated radionuclide with preferential tumor accumulation--the choice of radionuclide and chelating ligand.

Authors:  I Ogihara-Umeda; T Sasaki; H Nishigori
Journal:  Int J Rad Appl Instrum B       Date:  1992-10

6.  On the mode of liposome-cell interactions. Biotin-conjugated lipids as ultrastructural probes.

Authors:  E A Bayer; B Rivnay; E Skutelsky
Journal:  Biochim Biophys Acta       Date:  1979-02-02

7.  Tumor uptake of 67Ga-carrying liposomes.

Authors:  I Ogihara; S Kojima; M Jay
Journal:  Eur J Nucl Med       Date:  1986

8.  Iodoacetylated and biotinylated liposomes: effect of spacer length on sulfhydryl ligand binding and avidin precipitability.

Authors:  K Hashimoto; J E Loader; S C Kinsky
Journal:  Biochim Biophys Acta       Date:  1986-04-25
  8 in total
  2 in total

1.  Creating functional vesicle assemblies from vesicles and nanoparticles.

Authors:  Robert J Mart; Kwan Ping Liem; Simon J Webb
Journal:  Pharm Res       Date:  2009-04-23       Impact factor: 4.200

2.  Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.

Authors:  D Marshall; R B Pedley; R G Melton; J A Boden; R Boden; R H Begent
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.